Literature DB >> 30088483

Evaluation of the Tp-Te interval, Tp-Te/QTc ratio, and QT dispersion in patients with Turner syndrome.

Adem Atıcı, Cafer Panç, Ekrem Bilal Karaayvaz1, Ahmet Demirkıran, Orkide Kutlu, Kamber Kaşalı, Elmas Kekeç, Lütfullah Sarı, Zeynep Nur Akyol Sarı, Ahmet Kaya Bilge.   

Abstract

OBJECTIVE: To evaluate ventricular repolarization parameters using the interval from the peak to the end of the T wave (Tp-Te), together with QT and corrected QT (QTc) intervals, QT dispersion (QTd), and Tp-Te/QTc ratio in patients with Turner syndrome (pwTS) and to compare the results with those from healthy controls.
METHODS: In total, 38 patients previously diagnosed with Turner syndrome (TS) and 35 healthy girls (controls) were included in our cross-sectional study. Twelve-lead electrocardiography (ECG) and echocardiography after a 30-min rest were performed. The QT, QTc, QTd, Tp-Te interval, and Tp-Te/QTc ratio were determined.
RESULTS: No differences in age or sex were observed between the groups. QT intervals were similar in both groups [pwTS: 354.76±25.33 ms, controls (C): 353.29±17.51 ms, p=0.775]. pwTS had significantly longer QTc and QTd than controls (411.87±22.66 ms vs. 392.06±13.21 ms, p<0.001 and 40.31±2.02 ms vs. 37.54±1.83 ms, p<0.001, respectively). Similarly, the Tp-Te interval and Tp Te/QTc ratio were significantly longer in pwTS than in controls (71.89±3.39 ms vs. 65.34±2.88 ms, p<0.001 and 0.17±0.01 vs. 0.16±0.01, p=0.01).
CONCLUSION: As pwTS have longer QTc, QTd, Tp-Te interval, and Tp-Te/QTc ratio, an annual follow-up with ECG can provide awareness and even prevent sudden death in them. Also avoiding the use of drugs that makes repolarization anomaly and having knowledge about the side effects of these drugs are essential in pwTS.

Entities:  

Mesh:

Year:  2018        PMID: 30088483      PMCID: PMC6237954          DOI: 10.14744/AnatolJCardiol.2018.98250

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


  35 in total

Review 1.  The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart.

Authors:  C Antzelevitch; W Shimizu; G X Yan; S Sicouri; J Weissenburger; V V Nesterenko; A Burashnikov; J Di Diego; J Saffitz; G P Thomas
Journal:  J Cardiovasc Electrophysiol       Date:  1999-08

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

Review 3.  QT dispersion.

Authors:  P D Higham; R W Campbell
Journal:  Br Heart J       Date:  1994-06

4.  The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD.

Authors:  A G Stewart; J C Waterhouse; P Howard
Journal:  Respir Med       Date:  1995-02       Impact factor: 3.415

5.  Atrial and ventricular arryhthmogenic potential in Turner Syndrome.

Authors:  Ahmet B Sozen; Kivanç Cefle; Hasan Kudat; Sukru Ozturk; Huseyin Oflaz; Burak Pamukcu; Vakur Akkaya; Pinar Isguven; Sukru Palanduz; Mustafa Ozcan; Taner Goren; Ozen Guven
Journal:  Pacing Clin Electrophysiol       Date:  2008-09       Impact factor: 1.976

6.  QTc interval prolongation in children with Turner syndrome: the results of exercise testing and 24-h ECG.

Authors:  Robert Dalla Pozza; Susanne Bechtold; Simon Urschel; Heinrich Netz; Hans-Peter Schwarz
Journal:  Eur J Pediatr       Date:  2008-04-05       Impact factor: 3.183

7.  QT dispersion and sudden unexpected death in chronic heart failure.

Authors:  C S Barr; A Naas; M Freeman; C C Lang; A D Struthers
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

8.  Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.

Authors:  Katsuaki Miyajima; Shinya Minatoguchi; Yoko Ito; Masanori Hukunishi; Yasunari Matsuno; Masao Kakami; Masanori Kawasaki; Kazuhiko Nishigaki; Genzou Takemura; Hisayoshi Fujiwara
Journal:  Hypertens Res       Date:  2007-04       Impact factor: 3.872

Review 9.  Electrophysiological mechanisms of long and short QT syndromes.

Authors:  Gary Tse; Yin Wah Fiona Chan; Wendy Keung; Bryan P Yan
Journal:  Int J Cardiol Heart Vasc       Date:  2016-11-26

10.  Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.

Authors:  Christian Trolle; Kristian H Mortensen; Lisbeth N Pedersen; Agnethe Berglund; Henrik K Jensen; Niels H Andersen; Claus H Gravholt
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more
  5 in total

1.  The relationship between electrocardiographic data and mortality in children diagnosed with dilated cardiomyopathy.

Authors:  Mehmet Türe; Hasan Balık; Alper Akın; Meki Bilici; Ahmet Nergiz
Journal:  Eur J Pediatr       Date:  2020-01-14       Impact factor: 3.183

2.  Discordant results about QT prolongation in patients with Turner syndrome.

Authors:  Berhan Keskin; Abdülkadir Uslu; Tahir Bezgin
Journal:  Anatol J Cardiol       Date:  2018-11       Impact factor: 1.596

Review 3.  Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias.

Authors:  Virginie Grouthier; Melissa Y Y Moey; Estelle Gandjbakhch; Xavier Waintraub; Christian Funck-Brentano; Anne Bachelot; Joe-Elie Salem
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

4.  No QTc Prolongation in Girls and Women with Turner Syndrome.

Authors:  Iris D Noordman; Anthonie L Duijnhouwer; Misty Coert; Melanie Bos; Marlies Kempers; Henri J L M Timmers; Zina Fejzic; Janiëlle A E M van der Velden; Livia Kapusta
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

5.  Cardiac abnormalities in girls with Turner syndrome: ECG abnormalities, myocardial strain imaging, and karyotype-phenotype associations.

Authors:  Iris D Noordman; Zina Fejzic; Melanie Bos; Anthonie L Duijnhouwer; Gert Weijers; Marlies Kempers; Remy Merkx; Janiëlle A E M van der Velden; Livia Kapusta
Journal:  Am J Med Genet A       Date:  2021-05-10       Impact factor: 2.802

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.